Janus Kinase Inhibitors
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Janus Kinase Inhibitors, covering 2022-10-28 to 2025-10-01. Get the full timeline:
Most recent: Clinical Trial Update: Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D) [Phase 2]